Needham analyst Alex Henderson reiterates Infinera (NASDAQ:INFN) with a Strong Buy and maintains $15 price target.
Needham Reiterates Strong Buy on Infinera, Maintains $15 Price Target
Needham analyst Alex Henderson reiterates Infinera (NASDAQ:INFN) with a Strong Buy and maintains $15 price target.
Related Posts
RBC Capital Maintains Outperform on Rapid7, Raises Price Target to $157
RBC Capital analyst Matthew Hedberg maintains Rapid7 (NASDAQ:RPD) with a Outperform and raises the price target from $150 to $157.
Reported Late Wednesday, Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, announced that on
